Table 5.
Molecular Alterations in Study Cohort.
| N | % | |
|---|---|---|
| ETS Fusion | 22 | 55.0% | 
| PTEN | 17 | 42.5% | 
| TP53 | 11 | 27.5% | 
| WNT | 9 | 22.5% | 
| KMT2C | 8 | 20.0% | 
| SPOP | 6 | 15.0% | 
| PIK3 pathway | 5 | 12.5% | 
| CHD1 | 5 | 12.5% | 
| FoxA1 | 4 | 10.0% | 
| BRCA1/2 | 3 | 7.5% | 
| AR | 2 | 5.0% | 
| CDK12 | 2 | 5.0% | 
| ZFHX3 | 2 | 5.0% | 
| KRAS | 2 | 5.0% | 
| CCND1 | 1 | 2.5% | 
| ATM | 1 | 2.5% | 
| 8p loss | 35 | 87.5% | 
| 8q gain | 18 | 45.0% | 
| 13q loss | 18 | 45.0% | 
| 7p gain | 6 | 15.0% |